Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 SEK | +12.26% |
|
+3.48% | -60.79% |
06-18 | Alzinova AB Announces All Patients Have Been Recruited in the High-Dose Part of Alzinova's Phase 1B Study | CI |
06-10 | Alzinova AB Announces New External Safety Review for Phase 1b Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-60.79% | 4.51M | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- ALZ Stock
- News Alzinova AB
- EU Medicines Regulator OKs Alzinova's Clinical Development Program for Alzheimer's Drug Candidate